Literature DB >> 26185399

Error in Brilinta Pharmacokinetics.

Naeem Khan1.   

Abstract

Year:  2015        PMID： 26185399      PMCID： PMC4495865     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  2 in total

1.  Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin.

Authors:  Steen Husted; Håkan Emanuelsson; Stan Heptinstall; Per Morten Sandset; Mark Wickens; Gary Peters
Journal:  Eur Heart J       Date:  2006-02-13       Impact factor: 29.983

Review 2.  Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist.

Authors:  Steen Husted; J J J van Giezen
Journal:  Cardiovasc Ther       Date:  2009       Impact factor: 3.023
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.